Brittany Moncheck
Family · New Kensington, PANPI 1689251209
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 372 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 37.0% of the total. 2025 is the largest year on record at $1,480, 3.6 times the $406 reported in 2021. Among family clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 372 payments — averaging $13.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Alkermes, Inc.$654
- Teva Pharmaceuticals USA, Inc.$371
- Vanda Pharmaceuticals Inc.$299
- Johnson & Johnson$286
- Otsuka America Pharmaceutical, Inc.$256
- plus $1K from 15 others
What the payments were for
- Food & beverage$5,063100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 190 | $1,876 |
| Alkermes, Inc. | 33 | $654 |
| Teva Pharmaceuticals USA, Inc. | 18 | $371 |
| Vanda Pharmaceuticals Inc. | 15 | $299 |
| Johnson & Johnson | 15 | $286 |
| Otsuka America Pharmaceutical, Inc. | 15 | $256 |
| Axsome Therapeutics, Inc. | 21 | $240 |
| Neurocrine Biosciences, Inc. | 12 | $203 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $202 |
| Ironshore Pharmaceuticals Inc. | 9 | $175 |
| Supernus Pharmaceuticals, Inc. | 6 | $115 |
| Corium, LLC | 6 | $83 |
| Lundbeck LLC | 5 | $81 |
| Almatica Pharma LLC | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $55 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Sunovion Pharmaceuticals Inc. | 2 | $21 |
| Indivior Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| OWP Pharmaceuticals, Inc. | 1 | $12 |
| Tris Pharma Inc | 1 | $12 |
How this compares
$5,078 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorpromazine Hcl | 51 | $18,389 |
| Clomipramine Hcl | 13 | $6,186 |
| Quetiapine Fumarate | 53 | $2,391 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $2,044 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 12 | $1,011 |
| Oxcarbazepine | 40 | $844 |
| Buspirone Hcl | 32 | $494 |
| Fluvoxamine Maleate | 17 | $336 |
| Clonazepam | 40 | $271 |
| Hydroxyzine Pamoate | 29 | $169 |
| Lamotrigine | 15 | $111 |
| Fluoxetine Hcl | 15 | $108 |
| Citalopram HbrCitalopram Hydrobromide | 16 | $96 |
| Escitalopram Oxalate | 13 | $53 |
Paid to pharmacies, not to this prescriber.
Other family in New Kensington
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
- Patricia HabdasPittsburgh$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.